Ascendis Pharma A/S Work In Progress
Ascendis Pharma A/S (ASND) had Work In Progress of EUR 253.49 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:WorkInProgress · last filed 2026-02-11
- 2025-12-31: Work In Progress 253.49M EUR.
- 2024-12-31: Work In Progress 235.69M EUR.
- 2023-12-31: Work In Progress 171.03M EUR.
- 2022-12-31: Work In Progress 112.89M EUR.
| Period end | Work In Progress |
|---|---|
| 2025-12-31 | 253.49M EUR 20-F · filed 2026-02-11 |
| 2024-12-31 | 235.69M EUR 20-F · filed 2026-02-11 |
| 2023-12-31 | 171.03M EUR 20-F · filed 2025-02-12 |
| 2022-12-31 | 112.89M EUR 20-F · filed 2024-02-07 |
| 2021-12-31 | 68.86M EUR 20-F · filed 2023-02-16 |